Patent details

EP3350157 Title: COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

Basic Information

Publication number:
EP3350157
PCT Application Number:
US2016052352
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167818954
PCT Publication Number:
WO2017049245
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
French Title of Invention:
COMPOSÉS ET COMPOSITIONS POUR L'ADMINISTRATION INTRACELLULAIRE D'AGENTS THÉRAPEUTIQUES
German Title of Invention:
VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR INTRAZELLULÄREN VERABREICHUNG VON THERAPEUTISCHEN WIRKSTOFFEN
SPC Number:

Dates

Filing date:
16/09/2016
Grant date:
05/01/2022
EP Publication Date:
25/07/2018
PCT Publication Date:
23/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/01/2022
EP B1 Publication Date:
05/01/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/05/2022
 
 

Name:
ModernaTX, Inc.
Address:
200 Technology Square, Cambridge, MA 02139, United States (US)

History of Owners

From:
29/12/2021
To:
06/05/2022

Name:
Modernatx, Inc.
Address:
200 Technology Square, Cambridge, MA 02139, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
23/03/2022
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
KUMARASINGHE, Ellalahewage, Sathyajith
Address:
United States (US)

2

Name:
BENENATO, Kerry, E.
Address:
United States (US)

3

Name:
CORNEBISE, Mark
Address:
United States (US)

Priority

1

Priority Number:
201562220085 P
Priority Date:
17/09/2015
Priority Country:
United States (US)

2

Priority Number:
201562220091 P
Priority Date:
17/09/2015
Priority Country:
United States (US)

3

Priority Number:
201562252316 P
Priority Date:
06/11/2015
Priority Country:
United States (US)

4

Priority Number:
201562253433 P
Priority Date:
10/11/2015
Priority Country:
United States (US)

5

Priority Number:
201562266460 P
Priority Date:
11/12/2015
Priority Country:
United States (US)

6

Priority Number:
201662333557 P
Priority Date:
09/05/2016
Priority Country:
United States (US)

7

Priority Number:
201662382740 P
Priority Date:
01/09/2016
Priority Country:
United States (US)

8

Priority Number:
201662393940 P
Priority Date:
13/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07C 229/12; C07D 233/72; A61K 9/127; C07C 271/20; C07C 279/12; C07C 279/28; C07C 279/32; C07C 311/07; C07C 311/49; C07C 321/14; C07D 249/04; C07D 263/20; C07C 237/04; C07C 237/06; C07D 265/33; C07D 271/06; C07D 271/10; C07D 207/27; C07D 277/38;

Publication

European Patent Bulletin

1

Issue number:
202201
Publication date:
05/01/2022
Description:
Grant (B1)

2

Issue number:
202223
Publication date:
08/06/2022
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/09/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/03/2022 Outgoing Correspondence 1
23/03/2022 Power Of Attorney 2